In the CT26 colorectal cancer model, tumors presented complete adaptive resistance to anti-PD-1/CTLA-4, but the addition of anti-VISTA increases contact between T cells and myeloid cells, and reduces regulators of T cell quiescence, leading to clearance of half of the tumors [89]. Here, VSIR is linked to colorectal cancer.